AWM
AZN icon

Apollon Wealth Management’s AstraZeneca AZN Stock Holding History

Apollon Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4M Buy
97,297
+2,852
+3% +$536K 0.22% 89
2026
Q1 		$18.6M Buy
94,445
+61,830
+190% +$11.9M 0.3% 69
2025
Q4 		$6M Buy
32,615
+24,813
+318% +$4.35M 0.1% 176
2025
Q3 		$1.2M Buy
7,802
+165
+2% +$25K 0.02% 518
2025
Q2 		$1.07M Sell
7,637
-301
-4% -$42.2K 0.02% 534
2025
Q1 		$1.17M Buy
7,938
+40
+0.5% +$5.79K 0.03% 465
2024
Q4 		$1.03M Buy
7,898
+173
+2% +$24.2K 0.02% 505
2024
Q3 		$1.2M Sell
7,725
-63
-0.8% -$10.2K 0.03% 425
2024
Q2 		$1.21M Sell
7,788
-50
-0.6% -$7.52K 0.04% 408
2024
Q1 		$1.06M Sell
7,838
-5,647
-42% -$748K 0.03% 452
2023
Q4 		$1.82M Buy
13,485
+2,249
+20% +$292K 0.06% 287
2023
Q3 		$1.52M Buy
11,236
+3,288
+41% +$449K 0.08% 256
2023
Q2 		$1.14M Sell
7,948
-943
-11% -$139K 0.05% 355
2023
Q1 		$1.23M Sell
8,891
-1,532
-15% -$206K 0.08% 275
2022
Q4 		$1.41M Sell
10,423
-79
-0.8% -$9.91K 0.1% 214
2022
Q3 		$1.15M Buy
10,502
+4,484
+75% +$569K 0.09% 219
2022
Q2 		$795K Buy
6,018
+3,167
+111% +$416K 0.07% 315
2022
Q1 		$378K Sell
2,851
-2,243
-44% -$269K 0.03% 533
2021
Q4 		$593K Buy
5,094
+3,201
+169% +$377K 0.04% 418
2021
Q3 		$227K Buy
+1,893
New +$220K 0.03% 410
2020
Q3 		– Sell
-241
Closed -$25K – 199
2020
Q2 		$25K Buy
+241
New +$24.9K 0.01% 331

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Apollon Wealth Management's AZN Position: Q2 2026 in Review

Apollon Wealth Management increased its AstraZeneca (AZN) stake by 3% in Q2 2026, buying an estimated $536K and bringing the position to 97,297 shares worth $18.4M. The position accounts for 0.22% of the portfolio, ranked #89.

Apollon Wealth Management first reported a position in AZN in Q2 2020 and has held it in 21 quarters since. The position peaked at $18.6M in Q1 2026. 411 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Apollon Wealth Management held 97,297 shares of AstraZeneca worth $18.4M as of Q2 2026.
  • Apollon Wealth Management bought 2,852 AstraZeneca shares in Q2 2026, an estimated $536K.
  • AstraZeneca made up 0.22% of Apollon Wealth Management's portfolio in Q2 2026, its #89 holding.
  • Apollon Wealth Management first reported a position in AstraZeneca in Q2 2020 and has held it in 21 quarters since.
  • Apollon Wealth Management's AstraZeneca position peaked at $18.6M in Q1 2026.
  • 411 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.